dexfenfluramine has been researched along with Weight Gain in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bisaga, A; Danysz, W; Foltin, RW | 1 |
| Antier, D; Apfeldorfer, CS; Desbuards, N; Hanton, G; Hyvelin, JM; Rochefort, GY; Schenck, E | 1 |
| Brune, ME; Bush, EN; Droz, BA; Fey, T; Jacobson, PB; Knourek-Segel, VE; Lin, E; Shapiro, R | 1 |
| Antier, D; Bonnet, P; Eder, V; Hanton, G; Hyvelin, JM; Lemaire, MC; Rochefort, GY | 1 |
4 other study(ies) available for dexfenfluramine and Weight Gain
| Article | Year |
|---|---|
Antagonism of glutamatergic NMDA and mGluR5 receptors decreases consumption of food in baboon model of binge-eating disorder.
Topics: Animals; Appetite; Bulimia Nervosa; Candy; Conditioning, Operant; Consummatory Behavior; Dexfenfluramine; Dose-Response Relationship, Drug; Eating; Excitatory Amino Acid Antagonists; Female; Male; Memantine; Papio cynocephalus; Pyridines; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate; Reinforcement Schedule; Serotonin Receptor Agonists; Sex Characteristics; Thiazoles; Weight Gain | 2008 |
Dexfenfluramine discontinuous treatment does not worsen hypoxia-induced pulmonary vascular remodeling but activates RhoA/ROCK pathway: consequences on pulmonary hypertension.
Topics: Animals; Appetite Depressants; Dexfenfluramine; Enzyme Activation; Female; Gene Expression Regulation; Hemodynamics; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Lung; Rats; Rats, Wistar; rho-Associated Kinases; rhoA GTP-Binding Protein; RNA, Messenger; Signal Transduction; Weight Gain | 2009 |
Chronic treatment with either dexfenfluramine or sibutramine in diet-switched diet-induced obese mice.
Topics: Animals; Anti-Obesity Agents; Body Weight; Cyclobutanes; Dexfenfluramine; Diet, Fat-Restricted; Ghrelin; Growth Hormone; Male; Mice; Obesity; Peptide Hormones; Thinness; Weight Gain | 2006 |
Dexfenfluramine does not worsen but moderates progression of chronic hypoxia-induced pulmonary hypertension.
Topics: Animals; Blood Pressure; Body Weight; Chronic Disease; Dexfenfluramine; Disease Progression; Female; Heart Valve Diseases; Hypertension, Pulmonary; Hypoxia; Lung; Myocardium; Organ Size; Rats; Rats, Wistar; Serotonin Receptor Agonists; Ultrasonography, Doppler; Ventricular Function, Left; Ventricular Function, Right; Weight Gain | 2006 |